Clinical Trial Update: Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy

View source ↗

Summary

A clinical trial evaluating adjuvant therapy options for patients with non-pCR HER2-positive early breast cancer after neoadjuvant treatment is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shu Wang | Conditions: HER2-positive Breast Cancer | Status: RECRUITING